New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2013
12:30 EDTAAPL, MKC, DBD, ERJ, SWFT, TZOO, RTN, LMT, ALTR, BMY, SNDK, WDC, NFLX, LOGIOn The Fly: Midday Wrap
Wall Street's averages managed to withstand a disappointment from the biggest name in technology, Apple (AAPL), on the strength of some other encouraging earnings reports and PMI data from around the globe. The averages began the session mixed, with the Dow and S&P slightly higher and the Nasdaq deep in negative territory. As the morning progressed, the Dow and S&P added to their gains and the Nasdaq moved off its opening lows but was unable to cross over into positive territory... ECONOMIC EVENTS: In the U.S., weekly jobless claims fell last week to the lowest level in five years. Weekly unemployment applications dropped 5K to a seasonally adjusted 330K, which was below expectations for 360K. Markit's Flash U.S. Purchasing Managersí Index jumped to 56.1 in January from the 54.0 final print for December. The leading indicators increased 0.5% to 93.9 in December, versus an expected increase of 0.4%. In Europe, the composite euro zone Purchasing Managersí Index rose to 48.2 in January from 47.2 in December, beating expectations. In China, HSBC's flash PMI rose to 51.9 in January, slightly beating expectations for a 51.7 reading... COMPANY NEWS: The world's most valuable company, Apple, saw a fair amount of its market cap evaporate after the company's quarterly report disappointed investors. Despite earnings that beat consensus, Apple's revenue and iPhone sales fell short of expectations and the company said on its conference call that it is changing its approach to guidance, admitting it had been intentionally conservative in the past. Both Jefferies and Scotia Capital downgraded the shares, which declined 10.5% in midday trading... Netflix (NFLX) was upgraded by at least five firms after its earnings, subscriber additions and guidance all impressed. Shares were up nearly 38% near noon following its report... Among other large cap companies reporting results, Western Digital (WDC), SanDisk (SNDK) and Bristol-Myers (BMY) advanced, while Altera (ALTR), Lockheed Martin (LMT) and Raytheon (RTN) declined... MAJOR MOVERS: Among the notable gainers were Travelzoo (TZOO), up 25%, and Swift Transportation (SWFT), also up 25% after both beat earnings expectations. Also higher were shares of Embraer (ERJ), which rose almost 10% after Republic Airways (RJET) agreed to purchase 47 new aircraft from the company. Among the noteworthy losers were Diebold (DBD), down about 9%, McCormick (MKC), down 8%, and Logitech (LOGI), down 8% after their quarterly reports... INDICES: Near noon, the Dow was up 78.22, or 0.57%, to 13,857.55; the Nasdaq was down 8.66, or 0.27%, to 3,145.01; and the S&P 500 was up 3.90, or 0.26%, to 1,498.71.
News For AAPL;NFLX;WDC;SNDK;BMY;ALTR;LMT;RTN;TZOO;SWFT;ERJ;DBD;MKC;LOGI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | all recent news | >>
October 7, 2014
17:05 EDTAAPLApple iPhone gains market share among teens, says Piper
Piper Jaffray analyst Gene Munster concluded from Piper's 2014 Teen Survey that interest in Apple's technology remained strong among teens. According to the survey, teen iPhone ownership rose to 67% from 61% in the Spring, and iPad ownership among teens that owned a tablet remained at 66%, the same as in the Spring. However, teen interest in the Apple Watch remained "tepid," as only 16% of teens would be interested in an Apple Watch at $350. Shares are Overweight rated with a $120 price target.
16:35 EDTALTRAltera initiated with a Market Perform at Northland
Target $35.
16:00 EDTAAPL, NFLXOptions Update; October 7, 2014
iPath S&P 500 VIX Short-Term Futures up 2.16 to 32.24 Option volume leaders: AAPL TSLA TWTR AMZN FB VZ AA HTZ NFLX PBR according to Track Data.
15:01 EDTAAPLDunkin Donuts testing mobile ordering system, considering Apple Pay, NRN reports
Subscribe for More Information
14:46 EDTAAPLApple supplier GT Advanced recovers some of yesterday's losses
Subscribe for More Information
14:01 EDTRTNRaytheon breaks ground for new warehouse near Farmington, N.M.
Subscribe for More Information
14:00 EDTAAPLGT Advanced sapphire not used for iPhones because 'proved brittle,' WSJ says
Apple's (AAPL) decision to choose glass screens over GT Advanced's (GTAT) sapphire screens for the iPhone 6 was because of "tests in which the synthetic sapphire proved brittle, cracking when phones were dropped from various heights and angles," The Wall Street Journal reported last night, citing people familiar with the matter. Apple's decision to withhold GT Advanced's expected $139M payment was the tipping point for GT Advanced to declare bankruptcy, people familiar with the matter added. Reference Link
11:01 EDTLMTLockheed Martin signs exclusive agreement with European Aviation
Subscribe for More Information
10:29 EDTAAPLGT Advanced lists Apple, Airgas, GrafTech, Ultra Clean among top 30 creditors
Subscribe for More Information
10:17 EDTAAPLSamsung outlook miss weighs on suppliers
Subscribe for More Information
09:36 EDTNFLX, AAPLActive equity options trading on open
Subscribe for More Information
08:46 EDTAAPLFireEye announces targeted attack protection for Apple platform
Subscribe for More Information
08:34 EDTBMYBristol-Myers withdrawing NDA for asunaprevir
Given the rapidly evolving hepatitis C treatment landscape in the U.S., Bristol-Myers Squibb has decided that it will not pursue U.S. Food and Drug Administration approval of the dual regimen of daclatasvir and asunaprevir for the treatment of HCV genotype 1b patients in the United States and has therefore withdrawn its new drug application for asunaprevir, an NS3/4A protease inhibitor. The company will continue to pursue FDA approval of daclatasvir, a potent, pan-genotypic NS5A complex inhibitor, which is currently being investigated globally in multiple treatment regimens for HCV patients with high unmet need. Bristol-Myers says "The dual regimen was developed to meet the distinct need of the Japanese patient population, and we believe this treatment has the potential to play a major role in curing HCV patients in Japan, as well as in other markets where the HCV patient population is similar to Japan. In the EU, daclatasvir was recently approved for use in combination with other medicinal products across genotypes 1, 2, 3 and 4 for the treatment of HCV infection in adults. Similarly, we believe that daclatasvir-based regimens have the potential to fill continued unmet medical need in the U.S. and elsewhere in the world. We plan to submit additional data for daclatasvir to the FDA from our ongoing clinical trial program focused on difficult-to-treat patients, including patients with HCV genotype 3, patients who are pre- and post-liver transplant, and patients co-infected with HIV. Next month at the annual meeting of The American Association for the Study of Liver Diseases, we will present new data from several daclatasvir-based regimens. We look forward to bringing daclatasvir to patients in the U.S. and will continue to work closely with the FDA to advance our regulatory application, with the aim of bringing the investigational product to market as quickly as possible."
08:33 EDTBMYBristol-Myers withdrawing NDA for asunaprevir
Subscribe for More Information
08:15 EDTAAPLApple leaks point to iPad Air 2 with Touch ID, gold color, Michael Report says
Subscribe for More Information
07:34 EDTSNDKNetlist seeks preliminary injunction against SanDisk's ULLtradiMM
Subscribe for More Information
06:14 EDTAAPLSamsung may find difficulty competing with TSMC for Apple chips, DigiTimes says
Subscribe for More Information
06:11 EDTAAPLApple adjusts supply ratio for iPhone 6 and iPhone 6 Plus, DigiTimes reports
Subscribe for More Information
06:09 EDTAAPLApple 12-inch tablet may integrate both Mac OS and iOS, DigiTimes reports
Subscribe for More Information
06:06 EDTAAPLApple reinstated with a Buy at BofA/Merrill
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use